Taro Pharmaceutical Industries (TARO) BidaskScore is downgraded to Sold

Taro Pharmaceutical Industries

The BidaskScore of Taro Pharmaceutical Industries TAROTARO shows that the shares of the company are now TAROStrongly Bought Sold by investors.

The BidaskScore of the PharmaceuticalsPharmaceuticals shows that the sector is PharmaceuticalsStrongly Bought Sold since April 5.

Here are the BidAskScore of other related companies in the Pharmaceuticals sector:

Taro Pharmaceutical Industries Ltd. engages in the developmentˌ manufacturingˌ and marketing of prescription and over-the-counter pharmaceutical products in the U.S.ˌ Canadaˌ and Israel. Its products are used for dermatological and topicalˌ cardiovascularˌ neuropsychiatricˌ and anti-inflammatory therapeutic categories. It offers semi-solids formulations such as creams and ointments; and other dosage forms including liquidsˌ capsulesˌ and tablets. The company was founded in 1950 and is headquartered in Haifa Bayˌ Israel.

Taro Pharmaceutical Industries

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.